These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis. Nenadić N; Kirin BK; Letoja IZ; Plavec D; Topić RZ; Dodig S Pediatr Pulmonol; 2012 Apr; 47(4):401-8. PubMed ID: 21901862 [TBL] [Abstract][Full Text] [Related]
23. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country? Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095 [TBL] [Abstract][Full Text] [Related]
24. [Specific features of tuberculosis in childhood]. Delacourt C Rev Mal Respir; 2011 Apr; 28(4):529-41. PubMed ID: 21549907 [TBL] [Abstract][Full Text] [Related]
25. Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda. Bonnet M; Kyakwera C; Kyomugasho N; Atwine D; Mugabe F; Nansumba M; Ii YB; Mwanga-Amumpaire J; Kiwanuka J Int J Tuberc Lung Dis; 2017 Aug; 21(8):862-868. PubMed ID: 28786793 [TBL] [Abstract][Full Text] [Related]
26. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic. Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565 [TBL] [Abstract][Full Text] [Related]
27. Migration, TB control and elimination: Whom to screen and treat. Rendon A; Centis R; Zellweger JP; Solovic I; Torres-Duque CA; Robalo Cordeiro C; de Queiroz Mello FC; Manissero D; Sotgiu G Pulmonology; 2018; 24(2):99-105. PubMed ID: 29292196 [TBL] [Abstract][Full Text] [Related]
34. Community responses to HIV/TB in Canada: a discussion of issues addressed in the HIV/TB Project of the Canadian AIDS Society. Zack E Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S49-54. PubMed ID: 10688149 [No Abstract] [Full Text] [Related]
35. Optimizing the management of children with latent tuberculosis infection. Venturini E; Tersigni C; Chiappini E; de Martino M; Galli L Expert Rev Anti Infect Ther; 2017 Apr; 15(4):341-349. PubMed ID: 28074660 [TBL] [Abstract][Full Text] [Related]
36. Cochrane in context: Rifamycins compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Kadhiravan T; Tharyan P Evid Based Child Health; 2014 Mar; 9(1):295-7. PubMed ID: 25404582 [No Abstract] [Full Text] [Related]
37. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study. Santin M; Morandeira-Rego F; Alcaide F; Rabuñal R; Anibarro L; Agüero-Balbín R; Casas-Garcia X; Pérez-Escolano E; Navarro MD; Sánchez F; Coira-Nieto A; Trigo-Daporta M; Martinez-Meñaca A; Gonzalez-Cuevas A; López-Prieto MD; Domínguez-Castellano A; Jové N; Clin Microbiol Infect; 2016 Dec; 22(12):1007.e1-1007.e5. PubMed ID: 27647563 [TBL] [Abstract][Full Text] [Related]
38. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies. Druszczyńska M; Kowalewicz-Kulbat M; Fol M; Włodarczyk M; Rudnicka W Pol J Microbiol; 2012; 61(1):3-10. PubMed ID: 22708341 [TBL] [Abstract][Full Text] [Related]
39. Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada. Tyler AD; Randell E; Baikie M; Antonation K; Janella D; Christianson S; Tyrrell GJ; Graham M; Van Domselaar G; Sharma MK PLoS One; 2017; 12(10):e0185656. PubMed ID: 28982116 [TBL] [Abstract][Full Text] [Related]
40. [Aspects of latent tuberculosis revealed by photofluorographic surveys]. CALAMARI F Minerva Med; 1956 Oct; 47(84):1238-44. PubMed ID: 13387260 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]